(1) Ban TA. Fifty years chlorpromazine: a historical perspective. Neuropsychiatr Dis Treat. 2007 August; 3(4): 495–500 [Accesible en: http://www.ncbi.nlm.nih.gov/...
(2) Mazana JS, Pereira J, Cabrera R. Cincuenta años de clorpromazina. Rev Esp Sanid Penit 2002; 4: 101-113 [Accesible en: http://www.sanipe.es/OJS/index.php/RESP/...
(56) Sasvari Z, Bach S, Blondel M,Nagy PD. Inhibition of RNA recruitment and replication of an RNA virus by acri-
dine derivatives with known...
(55) Chung E, Prelli F, Dealler S, Lee WS, Chang YT, Wisniewski T. Styryl-based and tricyclic compounds as potential antiprion agents. PLoS...
(54) Boletín Oficial del Estado, 17 de agosto de 2012. Resolución de 2 de agosto de 2012, de la Dirección General de Carte- ra Básica de Servicios...
(53) Berk M, Dean OM, Cotton SM, Gama CS, Kapczinski F, Fernandes B, et al. Maintenance N-acetyl cysteine treatment for bipolar disorder:...
(52) Asevedo E, Cunha GR, Zugman A, Mansur RB, Brietzke E. N-acetylcysteine as a potentially useful medication to prevent conversion toschizophrenia...
(51) Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, Boulat O, et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity...
(3) Mitchell P. Chlorpromazine turns forty. Aust N Z J Psychiatry 1993; 27: 370-3 [Accesible en: http://anp.sagepub.com/content/27/3/370.full.pdf].
(4) De Bedia A. De la efectividad et la especificidad de las orasciones a los santos Cosme et Damián cuando de sanar los males de los hommes...
(5) Food and Drug Administration. Methylene Blue: Drug Safety Communication Serious CNS Reactions Possible When Given to Patients Taking Certain...
(6) Bender KJ. Methylene blue studied for bipolar as FDA issues warning. Psychiatric Times 10/5/2011 [Accesible en: http:// www.psychiatrictimes.com/bipolar-disorder/...
(7) Hamon J, Paraire J, Velluz J.Remarques sur l’action du 4560 RP sur l’agitation maniaque. Ann Méd Psychol (Paris) 1952; 110:331–5.
(8) King C, Voruganti LNP. What’s in a name? The evolution of the nomenclature of antipsychotic drugs. J Psychiatry Neurosci
2002; 27: 168-75...
(9) Healy D. The creation of psychopharmacology. Cambridge, Massachussets: Harvard University Press, 2002
(10) Lehmann HE. Before they called it Psychopharmacology. Neuropsychopharmacology 1993; 8: 291-303
(11) Etain B, Roubaud L. Jean Delay, M.D., 1907–1987. Am J Psychiatry 2002;159:1489 [Accesible en: http://ajp.psychiatryonline.org/article....
(12) Creese I, Burt R, Snyder SH. Dopamine receptor binding; differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol....
(13) Burt DR, Enna SJ, Creese I, Snyder SH. Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Natl Acad Sci U S A...
(14) Creese I, Burt R, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science...
(15) Lesem MD, Tran-Johnson TK, Riesenberg RA, Feifel D, Allen MH, Fish- man R, et al. Rapid acute treatment of agitation in individuals with...
(16) Bobon J, Bobon DP, Pinchard A, Collard J, Ban TA, De Buck R, Hippius H, et al. A new comparative physiognomy of neuroleptics: a collaborative...
(17) Leucht S, Pitschel-Walz G, Engel RR, Kissling W..Amisulpride, an unusual “atypical” antipsychotic: a meta-analysis of randomized controlled...
(19) Apiquian R, Fresan A, Ulloa RE, de la Fuente-Sandoval C, Herrera-Estrella M, Vazquez A, et al. Amoxapine as an atypical antipsychotic:...
(20) Dall’Igna OP, Tort AB, Souza DO, Lara DR. Cinnarizine has an atypical antipsychotic profile in animal models of psychosis J Psychopharmacol...
(21) Tort AB, Dall’Igna OP, de Oliveira RV, Mantese CE, Fett P, Gomes MW, et al. Atypical antipsychotic profile of flunarizine in animal models....
(22) Bisol LW, Brunstein MG, Ottoni GL, Ramos FL, Borba DL, Daltio CS, et al. Is flunarizine a long-acting oral atypical an- tipsychotic?...
(23) Jindal RD, Keshavan MS. Classifying antipsychotic agents : need for new terminology. CNS Drugs 2008; 22: 1047-59 [Abstract en: http://www.ncbi.nlm.nih.gov/...
(24) Balon C. Name for New Class of Antipsychotic Medications. Am J Psychiatry 2004; 161:930-931 [Accesible en: http://ajp.psychiatryonline.org/article....
(25) Healy D. The antidepressant era. Harvard: Harvard University Press, 1997
(26) Arbesú Prieto JA, Gonçalves Estella F, Madueño Caro AJ, Pérez Solà V, Villalta Macia L. Guía de buena práctica clínica en algoritmos...
(27) Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders:...
(28) Müller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, et al. Celecoxib treatment in an early stage of schizophrenia:...
(29) Bortolato M, Frau R, Orrù M, Bourov Y, Marrosu F, Mereu G, et al. Antipsychotic-like properties of 5-alpha-reductase inhibitors. Neuropsychopharmacology...
(30) Buie LW, Oertel MD, Cala SO. Allopurinol as adjuvant therapy in poorly responsive or treatment refractory schizophrenia. Ann Pharmacother....
(31) Plane JM, Shen Y, Pleasure DE, Deng W. Prospects for minocycline neuroprotection. Arch Neurol 2010; 67: 1442-8 [Accesible en: http://archneur.jamanetwork....
(32) Kato TA, Watabe M, Tsuboi S, Ishikawa K, Hashiya K, Monji A, et al. Minocycline modulates human social decision-making: possible impact...
(33) Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, et al. A double-blind, randomized study of minocycline for the...
(34) Bou Khalil R. Is there any place for macrolides in mood disorders? Med Hypotheses 2012; 78: 86-7 [Abstract en: http://www.ncbi.nlm.nih.gov/pubmed/22030071].
(35) Lu RB, Chen SL, Lee SY, Chang YH, Chen SH, Chu CH, et al. Neuroprotective and neurogenesis agent for treating bipolar II disorder: add-on...
(36) Lee JG, Lee SW, Lee BJ, Park SW, Kim GM, Kim YH. Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled...
(37) Muhonen LH, Lahti J, Sinclair D, Lönnqvist J, Alho H. Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors...
(38) Stewart SE, Jenike EA, Hezel DM, Stack DE, Dodman NH, Shuster L, et al. A single-blinded case-control study of memantine in severe obsessive-compulsivedisorder....
(39) Obregon DF, Velasco RM, Wuerz TP, Catalano MC, Catalano G, Kahn D. Memantine and catatonia: a case report and literature review. J Psychiatr...
(40) Dean O, Giorlando F, Berk M. Nacetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry...
(41) Ferreira Seiva FR, Amauchi JF, Ribeiro Rocha KK, et al. Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse...
(42) Gray KM, Carpenter MJ, Baker NL, Desantis SM, Kryway E, Hartwell KJ, et al. A double-blind randomized controlled trial of N-acetylcysteine...
(43) LaRowe SD, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, et al. Safety and tolerability of N-acetylcysteine in cocaine-dependent...
(44) Zhou W, Kalivas PW. N-acetyl- cysteine reduces extinction responding and induces enduring reductions in cueand heroin-induced drug-seeking....
(45) Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S, et al. The role of cystine-glutamate exchange in nicotine dependence...
(46) Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study....
(47) Berk M, Jeavons S, Dean OM, Dodd S, Moss K, Gama CS, et al. Nail-biting stuff? The effect of N-acetyl cysteine on nail biting.CNS Spectrums....
(48) Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a doubleblind, placebo-controlled...
(49) Odlaug BL, Grant JE. N-Acetyl Cysteine in the treatment of grooming disorders. J Clin Psychopharmacol 2007; 27:227– 229 [Abstract en:...
(50) Lafleur DL, Pittenger C, Kelmen- di B, Gardner T, Wasylink S, Malison RT, et al. N-acetylcysteine augmentation in serotonin reuptake...
(57) van Soolingen D, Hernandez-Pan- do R, Orozco H, Aguilar D, Magis-Escurra C, Amaral L, et al The antipsychotic thioridazine shows promising...
(58) Amaral L, Viveiros M. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections....
(59) Zhai B, Wu C, Wang L, Sachs MS, Lin X. The antidepressant sertraline provides a promising therapeutic option for
neurotropic cryptococcal...
(60) Sachlos E, Risueño RM, Laronde S, Shapovalova Z, Lee JH, Russell J, et al. Identification of drugs including a dopamine receptor antagonist...
(61) Durand JP, Deplanque G, Montheil V, Gornet JM, Scotte F, Mir O, et al. Efficacy of venlafaxine for the preven-
tion and relief of oxaliplatin-induced...
(62) Petrascheck M, Ye X, Buck LB.An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature 2007;450: 553-6 [Abstract...
(63) Zarse K, Ristow M. Anti- depressants of the serotonin-antagonist type increase body fat and decrease lifespan of adult Caenorhabditis...
